InVivo Therapeutics Corp Market cap
What is the Market cap of InVivo Therapeutics Corp?
The Market cap of InVivo Therapeutics Holdings Corp is $3.51M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NASDAQ compared to InVivo Therapeutics Corp
What does InVivo Therapeutics Corp do?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Companies with market cap similar to InVivo Therapeutics Corp
- Raptis has Market cap of $3.50M
- Stakeholder Gold has Market cap of $3.50M
- Alco has Market cap of $3.50M
- Dillistone Plc has Market cap of $3.50M
- Appreciated Media has Market cap of $3.50M
- Candela Invest SA has Market cap of $3.51M
- InVivo Therapeutics Corp has Market cap of $3.51M
- Southern Hemisphere Mining has Market cap of $3.51M
- Pinedale has Market cap of $3.51M
- Steed Oriental () has Market cap of $3.51M
- OCL Iron and Steel has Market cap of $3.51M
- Radient Technologies has Market cap of $3.51M
- Zenith Healthcare has Market cap of $3.51M